Financial Information of Onyx Biotec Limited IPO
The Revenues from operations for the Fiscals 2024, 2023 and 2022 were ₹5,387.43 Lakhs, ₹3,961.65 Lakhs and ₹4,498.09 Lakhs, respectively. The EBITDA for the Fiscals 2024, 2023 and 2022 were ₹840.77 Lakhs, ₹459.25 Lakhs and ₹575.79 Lakhs, respectively. The Profit after Tax for the Fiscals 2024, 2023 and 2022 was ₹303.16 Lakhs, ₹184.46 Lakhs and ₹335.29 Lakhs, respectively.
| Period Ended | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|
| Reserve of Surplus | 1,155.65 | 1,230.00 | 1,047.43 |
| Total Assets | 7,413.58 | 5,872.36 | 3,683.84 |
| Total Borrowings | 3,078.04 | 2,922.83 | 1,224.39 |
| Fixed Assets | 4,347.72 | 4,250.39 | 1,723.49 |
| Cash | 146.68 | 0.74 | 1.36 |
| Net Borrowing | 2,931.36 | 2,922.09 | 1,223.03 |
| Revenue | 5,387.43 | 3,961.65 | 4,498.09 |
| EBITDA | 840.77 | 459.25 | 575.79 |
| PAT | 303.16 | 184.46 | 335.29 |
| EPS | 2.54 | 1.56 | 2.84 |
Note 1:- RoE & ROCE calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue, given in Price Band Advertisement.
Copyright @2020 Design & Developed by Info Web Software